Morphine Sulfate Injection — Class I drug recall D-1419-2012
Terminated recall by Hospira Inc., reported 2012-07-25, distributed nationwide. Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL
| Recall number | D-1419-2012 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2012-04-17 |
| Classified | 2012-07-15 |
| Reported by FDA | 2012-07-25 |
| Terminated | 2015-05-29 |
| Distributed | Nationwide (US) |
| Quantity | 212,370 cartidges |
| Reason classes | labeling, potency |
| NDC | 00409-1258-30 |
| Lot numbers | 10830LL |
| Expiration dates | 2013-04-01 |
Product
Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge Unit with Luer Lock, packaged 10 Carpujects/carton, CII, Rx only, Hospira, Inc., Lake Forest, IL ---- NDC 0409-1258-30
Reason for recall
Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1419-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.